Is Ipamorelin Legal? FDA, Compounding and WADA Status
Ipamorelin's FDA status, compounding rules and anti-doping status, with a dated timeline of every change we track.
- FDA status
- Not approved
- research chemical
- PCAC vote
- Not reviewed
- not on the Jul 2026 PCAC agenda
- WADA
- Prohibited (S2.2.4)
- In and out of competition
Current status
Not FDA approved · research chemicalNo. Ipamorelin is not FDA approved for any use.
| Country | Status | Source |
|---|---|---|
| United States | No approved product foundNo FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "ipamorelin" returned no matches on 2 Oct 2026. | api.fda.govchecked 2 Oct 2026 |
Timeline
- FDA warning letters to five research-peptide sellersEnforcement
Compounding and research-use sellers
- Category 2 is the FDA's list of bulk substances it flagged as raising significant safety concerns. Compounding pharmacies are not expected to compound from them while they are on it.
- The Pharmacy Compounding Advisory Committee (PCAC) advises the FDA on which substances belong on the 503A bulks list that pharmacies may compound from. Its votes are advice; the FDA decides.
- "Research use only" products are sold outside these rules and are not checked by the FDA for identity, purity or dose.
FDA compounding record: Ipamorelin acetate is in FDA's 503B category 2 (added 29 September 2023). · fda.gov, checked 2 Oct 2026
Sport and drug testing
Prohibited by WADA (S2.2.4)Ipamorelin is named as a growth hormone secretagogue in S2.2.4, prohibited at all times.
Outside the US
Rules differ by country. What each regulator's own records show, with the date we checked:
| Country | Status | Source |
|---|---|---|
| United Kingdom | No approved product foundNo approved product found in an emc (UK SmPC compendium) search for "ipamorelin" on 2 Oct 2026. | medicines.org.ukchecked 2 Oct 2026 |
| Canada | No approved product foundNo product found in a Health Canada Drug Product Database search for ingredient "ipamorelin" on 2 Oct 2026. | health-products.canada.cachecked 2 Oct 2026 |
| Australia | No approved product foundNo approved product found in an ARTG search for "ipamorelin" on 2 Oct 2026. | tga.gov.auchecked 2 Oct 2026 |
| European Union | No centrally authorised EU medicine foundEMA medicines list, searched 2 Oct 2026 | ema.europa.euchecked 2 Oct 2026 |
Ipamorelin is the one that stayed on the safety-risk list
FDA’s page lists Ipamorelin acetate in the main safety-risk table for outsourcing facilities (503B), added on September 29, 2023.[3]
The same page repeats the ipamorelin entry in its withdrawn-nominations table with the note that it also appears in the table above because it is in category 2 under the 503B interim policy.[3]
FDA's stated concern includes a literature report of serious adverse events including death when ipamorelin was given intravenously for gastric motility.[3]
Two further concerns appear in FDA's entry: compounded ipamorelin may trigger an immune response for certain routes because of aggregation or peptide-related impurities, and its unnatural amino acids make the peptide harder to characterise.[3]
What the April 2026 notice did not cover
The April notice concerned removals from Category 2 under the interim policy guidance; ipamorelin's listing is a separate entry described above.[9]
FDA's 503A Category 2 list, updated May 14, 2026, is a short list of other bulk drug substances (cesium chloride and domperidone among them).[10]
Sellers, blends and sport
An August FDA warning letter quoted a seller's marketing for a blend of tesamorelin and ipamorelin and listed that blend among unapproved new drugs.[11]
WADA names ipamorelin as an example of a growth hormone secretagogue in S2.2.4.[1]
The one randomized human trial in the evidence file gave intravenous ipamorelin infusions after bowel surgery.[12]
Common questions
Is ipamorelin FDA approved?
No. Drugs@FDA returns no match for ipamorelin.[2]
Is Ipamorelin legal to buy?
It is not an approved drug. Online sellers label it "for research use only, not for human use"; the FDA sent warning letters to five such sellers on 24 Aug 2026. Whether a pharmacy may compound it depends on its FDA bulk-substance status. Rules differ by country.
Is Ipamorelin banned by WADA?
Yes. Prohibited by WADA (S2.2.4), in and out of competition.
Ipamorelin FDA approval: what does FDA say about it?
FDA says it has not identified safety-related information for ipamorelin by certain other injectable routes, and so lacks sufficient information on whether those routes would harm humans.[3]
Is ipamorelin banned?
In sport, yes: WADA names it under growth hormone secretagogues.[1]
More on Ipamorelin
Sources
- 1World Anti-Doping Code International Standard Prohibited List 2026World Anti-Doping Agency · 2026wada-ama.orgAccessed 2 Oct 2026
- 2United States: No FDA-approved product found: Drugs@FDA (openFDA) search for active ingredient "ipamorelin" returned no matches on 2 Oct 2026.U.S. Food and Drug Administration · 2026api.fda.govAccessed 2 Oct 2026
- 3US compounding: Ipamorelin acetate is in FDA's 503B category 2 (added 29 September 2023).U.S. Food and Drug Administration · 2026fda.govAccessed 2 Oct 2026
- 4United Kingdom: No approved product found in an emc (UK SmPC compendium) search for "ipamorelin" on 2 Oct 2026.Electronic Medicines Compendium (UK) · 2026medicines.org.ukAccessed 2 Oct 2026
- 5Canada: No product found in a Health Canada Drug Product Database search for ingredient "ipamorelin" on 2 Oct 2026.Health Canada · 2026health-products.canada.caAccessed 2 Oct 2026
- 6Australia: No approved product found in an ARTG search for "ipamorelin" on 2 Oct 2026.Therapeutic Goods Administration (Australia) · 2026tga.gov.auAccessed 2 Oct 2026
- 7EMA medicines export (centrally authorised medicines) (searched 2 Oct 2026)European Medicines Agency · 2026ema.europa.euAccessed 2 Oct 2026
- 8FDA warning letters to five research-peptide sellersFDA warning letter (NuScience Peptides; 1 of 5) · 2026fda.govAccessed 2 Oct 2026
- 9Official web pageOfficial web page · web page
- 10Official web pageOfficial web page · web page
- 11Official web pageOfficial web page · web page
- 12Prospective, randomized, controlled, proof-of-concept study of the Ghrelin mimetic ipamorelin for the management of postoperative ileus in bowel resection patients.International journal of colorectal disease · 2014PMID 25331030Accessed 2 Oct 2026
Found an error? Report a correction.